Curogen has been selected for the 2024 Korea Drug Development Fund (KDDF) research grant. The research project sector is 'Expanding Drug Development Foundations' and focuses on lead compound stage assets. This project is set to begin from April 2024 until April 2026, with a grant budget of 800 million KRW.